TransCode Therapeutics, Inc. (RNAZ)
1.76
-0.13
(-6.88%)
USD |
NASDAQ |
Sep 09, 14:02
TransCode Therapeutics Market Cap : 1.780M for Sept. 9, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 08, 2026 | 1.912M |
| September 04, 2026 | 2.084M |
| September 03, 2026 | 2.18M |
| September 02, 2026 | 2.033M |
| September 01, 2026 | 2.084M |
| August 31, 2026 | 2.124M |
| August 28, 2026 | 2.205M |
| August 27, 2026 | 2.306M |
| August 26, 2026 | 2.367M |
| August 25, 2026 | 2.559M |
| August 24, 2026 | 2.731M |
| August 21, 2026 | 2.903M |
| August 20, 2026 | 3.004M |
| August 19, 2026 | 3.247M |
| August 18, 2026 | 3.278M |
| August 17, 2026 | 3.197M |
| August 14, 2026 | 3.318M |
| August 13, 2026 | 3.520M |
| August 12, 2026 | 3.409M |
| August 11, 2026 | 3.145M |
| August 10, 2026 | 3.558M |
| August 07, 2026 | 3.631M |
| August 06, 2026 | 3.916M |
| August 05, 2026 | 3.897M |
| August 04, 2026 | 4.081M |
| Date | Value |
|---|---|
| August 03, 2026 | 3.870M |
| July 31, 2026 | 4.182M |
| July 30, 2026 | 4.814M |
| July 29, 2026 | 4.548M |
| July 28, 2026 | 4.585M |
| July 27, 2026 | 4.998M |
| July 24, 2026 | 5.438M |
| July 23, 2026 | 6.648M |
| July 22, 2026 | 7.703M |
| July 21, 2026 | 7.703M |
| July 20, 2026 | 8.005M |
| July 17, 2026 | 7.730M |
| July 16, 2026 | 7.584M |
| July 15, 2026 | 7.973M |
| July 14, 2026 | 7.868M |
| July 13, 2026 | 7.850M |
| July 10, 2026 | 8.097M |
| July 09, 2026 | 8.799M |
| July 08, 2026 | 7.221M |
| July 07, 2026 | 7.740M |
| July 06, 2026 | 7.125M |
| July 02, 2026 | 7.895M |
| July 01, 2026 | 7.015M |
| June 30, 2026 | 5.695M |
| June 29, 2026 | 4.805M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 11.78B |
| Oncolytics Biotech, Inc. | 100.33M |
| Sangamo Therapeutics, Inc. | 66.66M |
| Sarepta Therapeutics, Inc. | 2.341B |
| Anixa Biosciences, Inc. | 95.66M |
Market Cap Related Metrics
| Price | 1.76 |
| Earnings Yield | -2.88K% |